← back to search

Qikai Xu

Thomas Jefferson University · US
Area of research
Molecular Biology · Immunology
Research interest
Research interests include Immunotherapy and Immune Responses, CAR-T cell therapy research, Ubiquitin and proteasome pathways, and Epigenetics and DNA Methylation.
h-index
29
citations
8,216
works
58
NIH funding
primary concept
email

Recent publications

TScan-II: A genome-scale platform for the de novo identification of CD4+ T cell epitopes
Cell 2023cited by 46position: middledoi
Phenotype, specificity and avidity of antitumour CD8+ T cells in melanoma
Nature 2021cited by 537position: middledoi
Integrated proteogenetic analysis reveals the landscape of a mitochondrial-autophagosome synapse during PARK2-dependent mitophagy
Science Advances 2019cited by 77position: middledoi
Diversified Application of Barcoded PLATO (PLATO-BC) Platform for Identification of Protein Interactions
Genomics Proteomics & Bioinformatics 2019cited by 11position: middledoi
The Eukaryotic Proteome Is Shaped by E3 Ubiquitin Ligases Targeting C-Terminal Degrons
Cell 2018cited by 343position: middledoi
Profound Tissue Specificity in Proliferation Control Underlies Cancer Drivers and Aneuploidy Patterns
Cell 2018cited by 241position: middledoi
Systematic autoantigen analysis identifies a distinct subtype of scleroderma with coincident cancer
Proceedings of the National Academy of Sciences 2016cited by 106position: middledoi
Sources of Error in Mammalian Genetic Screens
G3 Genes Genomes Genetics 2016cited by 90position: middledoi
Profiling DNA damage-induced phosphorylation in budding yeast reveals diverse signaling networks
Proceedings of the National Academy of Sciences 2016cited by 61position: middledoi
The DNA damage response induces inflammation and senescence by inhibiting autophagy of GATA4
Science 2015cited by 975position: middledoi
Comprehensive serological profiling of human populations using a synthetic human virome
Science 2015cited by 499position: middledoi
Comprehensive Identification of Host Modulators of HIV-1 Replication using Multiple Orthologous RNAi Reagents
Cell Reports 2014cited by 58position: middledoi
STOP gene <i>Phactr4</i> is a tumor suppressor
Proceedings of the National Academy of Sciences 2013cited by 26position: middledoi
Tiling genomes of pathogenic viruses identifies potent antiviral shRNAs and reveals a role for secondary structure in shRNA efficacy
Proceedings of the National Academy of Sciences 2012cited by 31position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Stephen J. Elledge · Harvard University13 papers (2012–2023)Mamie Z. Li · Howard Hughes Medical Institute10 papers (2012–2019)Teresa Davoli · NYU Langone Health4 papers (2013–2018)Tomasz Kula · Harvard University3 papers (2015–2023)Hongjing Qu · Medicon2 papers (2012–2014)Aylwin Ng · Massachusetts Institute of Technology2 papers (2014–2016)Jian Zhu · Nanjing Agricultural University2 papers (2014–2019)Timothy D. Martin · Brigham and Women's Hospital2 papers (2015–2018)Geng Gao · Brigham and Women's Hospital2 papers (2012–2014)George Xu · Vanderbilt University Medical Center2 papers (2015–2016)Yumei Leng · Harvard University2 papers (2018–2023)Laura M. Sack · Brigham and Women's Hospital2 papers (2016–2018)Anthony C. Liang · Brigham and Women's Hospital2 papers (2013–2018)Kwok‐Kin Wong · NYU Langone Health2 papers (2013–2018) · 1 papers (2015–2015)Tao Lu · Indiana University School of Medicine1 papers (2015–2015) · 1 papers (2023–2023) · 1 papers (2023–2023)Suzanne D. Vernon · Jackson Laboratory1 papers (2015–2015)Scott W. Lowe · Memorial Sloan Kettering Cancer Center1 papers (2012–2012)